[Hepatits B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy and effective prophylactic management: a prospective observational study in a hospital over an 8-year period].

We investigated the development of hepatits B virus (HBV) reactivation in patients receiving immunosuppressive therapy or chemotherapy at our hospital for 8 years. Using the automatic checking system for HBV reactivation coded using medical information that has been in operation in our hospital since October 2012, we prospectively observed the occurrence status of HBV reactivation in immunosuppressive/chemotherapy cases for 8 years. HBV reactivation occurred in 31 of 1516 patients with HBV infection. It occurred annually between 1 and 7 cases in multiple clinical departments, and in 8 of 59 patients treated with rituximab, 10 of 653 patients treated with antineoplastic agents, 10 of 399 patients treated with steroids, and 3 of 212 patients treated with direct-acting antivirals. The cumulative incidence of HBV reactivation was 1.2%, 2.3%, and 3.4% at 1, 2, and 3 years, respectively. The results of Cox regression analysis showed that the incidence of HBV reactivation was significantly higher in patients who received rituximab (odds ratio:12.841) or steroid (hazard ratio:4.264) or those who tested positive for HBc antibody alone (hazard ratio:11.005). We observed the occurrence of HBV reactivation in HBV-infected patients treated with immunosuppressive therapy or chemotherapy. HBV reactivation by immunosuppressive therapy or chemotherapy still occurs, and further safety management and caution are required in the hospital.

Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors.

Microbiota in the gut and oral cavities of pancreatic cancer (PC) patients differ from those of healthy persons, and bacteria in PC tissues are associated with patients' prognoses. However, the species-level relationship between a dysbiotic gut, oral and cancerous microbiota, and prognostic factors remains unknown. Whole-genome sequencing was performed with fecal DNA from 24 PC patients and 18 healthy persons (HD). Microbial taxonomies, metabolic pathways, and viral presence were determined. DNA was sequenced from saliva and PC tissues, and the association between the gut, oral, and cancer microbiota and prognostic factors in PC patients was analyzed. The PC microbiota were altered from those of the healthy microbiota in terms of microbial taxonomy, pathways and viral presence. Twenty-six species differed significantly between the PC and HD microbiota. Six fecal microbes, including Klebsiella pneumoniae, were associated with an increased hazard of death. In the co-occurrence network, microbes that were abundant in PC patients were plotted close together and formed clusters with prognosis-associated microbes, including K. pneumoniae. Multiple salivary microbes were present in the co-occurrence network. Microbacterium and Stenotrophomonas were detected in the PC tissues and formed a network with the fecal and salivary microbes. The dysbiotic gut microbiota in the PC patients formed a complex network with the oral and cancerous microbiota, and gut microbes abundant in the PC patients were closely linked with poor prognostic factors in the network.

Autonomic and perceptual thermoregulatory responses to voluntarily engaging in a common thermoregulatory behaviour.

We examined whether partial clothing removal is an effective thermoregulatory behaviour to attenuate both thermoregulatory and perceptual strain in a moderate environment (23 °C, 65% RH) during and after exercise. Ten healthy males (age: 21.9 (0.9) years; height: 173.9 (6.2) cm; mass: 62.3 (8.2) kg; body surface area: 1.8 (0.1) m2; VO2max: 51.8 (13.3) mL.kg-1.min-1) wore a long sleeve polyester shirt and performed two randomized cycling trials for 40 min at 40% VO2max followed by 20 min recovery. In one trial, they were permitted to roll up their sleeves at any time they wanted (Roll) whereas in the other trial, they were instructed to remain with long sleeves (No Roll) until the end of the recovery. Thermoregulatory variables were measured continuously whilst thermal perceptions (forearm wettedness perception (WPForearm), forearm and whole-body thermal discomfort (TDForearm, TDWhole), local and whole-body thermal sensation (TSForearm, TSWhole) and whole-body wettedness perception (WPwhole)) were measured every 10 min. All subjects behaved by rolling up their sleeves at 21.6 (4.7) minutes. Tskin (32.3 (0.2) °C, vs 32.0 (0.1) °C, p = 0.03), local sweat rate on the forearm (0.24 (0.08) mg.cm-2.min-1 vs 0.2 (0.04) mg.cm-2.min-1, p = 0.05), WPForearm, TDForearm, TSForearm and WPWhole were all lower in Roll than No Roll (all p < 0.05) whilst Tcore and cutaneous vascular conductance (CVC) on the forearm were not different (all p > 0.7) throughout the entire trial. We conclude that this behavioural response is an effective thermoregulatory behaviour to modulate local sudomotor function and thermal perceptions, WPWhole during exercise but only Tsk, TDForearm WPForearm and WPWhole persisted throughout the recovery in a moderate environment.

Fast and stable vapochromic response induced through nanocrystal formation of a luminescent platinum(II) complex on periodic mesoporous organosilica.

A hybrid vapoluminescent system exhibiting fast and repeatable response was constructed using periodic mesoporous organosilica with bipyridine moieties (BPy-PMO) and a Pt(II) complex bearing a potentially luminescent 2-phenylpyridinato (ppy) ligand. An intense red luminescence appeared when the Pt(II)-complex immobilised BPy-PMO was exposed to methanol vapour and disappeared on exposure to pyridine vapour. The ON-OFF vapochromic behaviour occurred repeatedly in a methanol/pyridine/heating cycle. Interestingly, a rapid response was achieved in the second cycle and cycles thereafter. Scanning and transmission electron microscopies (SEM/TEM), absorption and emission, and nuclear magnetic resonance spectroscopies, mass spectrometry, and powder X-ray diffraction indicated that methanol vapour induced Si-C cleavage and thus liberated [Pt(ppy)(bpy)]Cl (bpy = 2,2'-bipyridine) from the BPy-PMO framework. Furthermore, the self-assembling properties of the Pt(II) complex resulted in the formation of highly luminescent micro/nanocrystals that were homogeneously dispersed on the porous support. The unique vapoluminescence triggered by the unprecedented protodesilylation on exposure to protic solvent vapour at room temperature is attributable to BPy-PMO being a giant ligand and an effective vapour condenser. Consequently, this hybrid system presents a new strategy for developing sensors using bulk powdery materials.